![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Matsumoto, M Yoshioka, H Togashi, M Tochihara, T Ikeda and H Saito
First Department of Pharmacology, Hokkaido University School of Medicine, Sapporo, Japan.
The functional modulation of norepinephrine (NE) release by serotonergic receptors in the hippocampus of freely moving rats was studied by use of in vivo microdialysis. To stimulate NE release from the nerve terminals, a high concentration of potassium (K+, 120 mM) was added through the perfusion system. The K(+)-evoked NE release was inhibited in a concentration-dependent manner when serotonin (5-HT, 0.01-10 microM) was coperfused with K+. A selective 5-HT3 receptor agonist, 2-methyl-5-HT, mimicked the 5-HT response at a concentration of 0.01 to 10 microM. The 5-HT-induced (1 microM) inhibition of NE release was blocked by pretreatment with ondansetron (1 and 10 microM), a 5-HT3 receptor antagonist. On the other hand, K(+)-evoked NE release was also reduced by coperfusion with the 5-HT reuptake inhibitor, fluoxetine (10 microM), which caused increases in the dialysate 5-HT concentration. The fluoxetine-induced (10 microM) decreases in the K(+)- evoked NE release were prevented by serotonergic denervation caused by pretreatment with 5,7-dihydroxytryptamine (200 micrograms/rat i.c.v.). These results indicate that the inhibition on NE release by fluoxetine was due to increased synaptic concentrations of endogenous 5-HT. The fluoxetine-induced inhibitory effect was furthermore abolished by pretreatment with ondansetron (1 and 10 microM). These findings indicate the possibility that both exogenous and endogenous 5-HT inhibit NE release occurs from the rat hippocampus by 5-HT3 receptors. Thus, the present study suggests that the functional modulation of NE release by 5-HT3 receptors exists in vivo.
This article has been cited by other articles:
|
|
 |
|
  K. B. Fink and M. Gothert 5-HT Receptor Regulation of Neurotransmitter Release Pharmacol. Rev., December 1, 2007; 59(4): 360 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tachibana, M. Matsumoto, H. Koseki, H. Togashi, T. Kojima, Y. Morimoto, and M. Yoshioka Electrophysiological and neurochemical characterization of the effect of repeated treatment with milnacipran on the rat serotonergic and noradrenergic systems J Psychopharmacol, July 1, 2006; 20(4): 562 - 569. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Melke, L. Westberg, S. Nilsson, M. Landen, H. Soderstrom, F. Baghaei, R. Rosmond, G. Holm, P. Bjorntorp, L.-G. Nilsson, et al. A Polymorphism in the Serotonin Receptor 3A (HTR3A) Gene and Its Association With Harm Avoidance in Women Arch Gen Psychiatry, October 1, 2003; 60(10): 1017 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Harrell and A. M. Allan Improvements in Hippocampal-Dependent Learning and Decremental Attention in 5-HT3 Receptor Overexpressing Mice Learn. Mem., September 1, 2003; 10(5): 410 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Simonneaux and C. Ribelayga Generation of the Melatonin Endocrine Message in Mammals: A Review of the Complex Regulation of Melatonin Synthesis by Norepinephrine, Peptides, and Other Pineal Transmitters Pharmacol. Rev., June 1, 2003; 55(2): 325 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Crissman and J. M. O'Donnell Effects of Antidepressants in Rats Trained to Discriminate Centrally Administered Isoproterenol J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 606 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Daws, G. M. Toney, G. A. Gerhardt, and A. Frazer In Vivo Chronoamperometric Measures of Extracellular Serotonin Clearance in Rat Dorsal Hippocampus: Contribution of Serotonin and Norepinephrine Transporters J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 967 - 976. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Popoli, A. Venegoni, C. Vocaturo, L. Buffa, J. Perez, E. Smeraldi, and G. Racagni Long Term Blockade of Serotonin Reuptake Affects Synaptotagmin Phosphorylation in the Hippocampus Mol. Pharmacol., January 1, 1997; 51(1): 19 - 26. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
